Related Experiment Video
Updated: Dec 30, 2025

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR
Published on: May 16, 2012
miR-181a-5p is downregulated and inhibits proliferation and the cell cycle in prostate cancer
Hao Shen1, Xiao-Dong Weng1, Xiu-Heng Liu1
1Department of Urology, Renmin Hospital of Wuhan University Wuhan, Hubei, China.
Abstract:
Prostate cancer (PCa) is one of the most common cancers in men worldwide. However, the detailed molecular mechanisms underlying PCa tumorigenesis and progression remain largely unclear. MicroRNAs are key regulators of gene post-transcriptional expression in human cancer. In this study, we used public datasets, including GSE21036, GSE14857 and GSE45604 to analyze the expression of miR-181a in PCa. We also explored the potential role of miR-181a by using bioinformatics analysis and gain of function assay. miR-181a was down-regulated in PCa. Bioinformatics analysis revealed miR-181a was significantly involved in regulating cell metabolic process and gene expression. Of note, gain of function assay results showed overexpression of miR-181a could significantly inhibit cell proliferation by inducing G1 cell cycle arrest. Our results suggest miR-181a-5p may be adiagnostic and therapeutic biomarker for prostate cancer.
Insights
MicroRNA-181a (miR-181a) is down-regulated in prostate cancer (PCa). Overexpressing miR-181a inhibits PCa cell proliferation, suggesting its potential as a diagnostic and therapeutic biomarker.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Prostate cancer (PCa) is a prevalent malignancy in men globally.
- The molecular underpinnings of PCa development and progression require further elucidation.
- MicroRNAs (miRNAs) are critical regulators of gene expression in cancer.
Purpose of the Study:
- To investigate the expression and function of miR-181a in prostate cancer.
- To explore the potential of miR-181a as a biomarker for PCa.
Main Methods:
- Analysis of public datasets (GSE21036, GSE14857, GSE45604) for miR-181a expression in PCa.
- Bioinformatics analysis to identify pathways regulated by miR-181a.
- Gain-of-function assays to assess the impact of miR-181a overexpression on PCa cells.
Main Results:
- miR-181a expression was found to be significantly downregulated in PCa tissues.
- Bioinformatics analysis indicated miR-181a's involvement in cell metabolic processes and gene expression regulation.
- Overexpression of miR-181a inhibited PCa cell proliferation by inducing G1 cell cycle arrest.
Conclusions:
- miR-181a plays a suppressive role in prostate cancer progression.
- miR-181a-5p demonstrates potential as a diagnostic and therapeutic biomarker for PCa.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
MicroRNAs
MicroRNAs
Inhibition of Cdk Activity
Mitogens and the Cell Cycle

